Weil Serves as Antitrust Counsel to Actavis in the Sale of its Branded Respiratory Portfolio to AstraZeneca

Weil’s Antitrust team is representing Actavis in the just announced sale of its Branded Respiratory Portfolio to AstraZeneca, a transaction valued at $600 million. The transaction is subject to antitrust regulatory approval as well as customary closing conditions, and is expected to close in the first quarter of 2015. More >>

Tags:  Weil, Gotshal & Manges, LLP | Washington

Simpson Thacher Represents Greenhill & Co. in Connection with Frontier Communications’ $10.54 Billion Acquisition of Verizon’s California, Florida and Texas Wireline Operations

The Firm is representing Greenhill & Co. as advisor to Frontier Communications Corporation’s (NASDAQ: FTR) Board of Directors in connection with Frontier Communications’ proposed acquisition of Verizon Communications Inc.’s (NYSE: VZ) (“Verizon”) wireline operations that provide services to residential, commercial and wholesale customers in California, Florida and Texas, for $10.54 billion in cash. These Verizon properties include 3.7 million voice connections, 2.2 million broadband connection, and 1.2 million FiOS® video connections. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in the first half of 2016. More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Renowned Corporate Lawyer Kathleen Smalley Joins Locke Lord As Firm Expands, Enhances Resources in Los Angeles Market

Kathleen Smalley, who represents clients in complex transactions and high-stakes litigation with an emphasis on matters concerning governance of both public and private companies, has joined Locke Lord as a Partner in Los Angeles. She will be part of the Firm’s Finance, Banking and Real Estate Department and its Real Estate Practice Group. More >>

Tags:  Locke Lord LLP | Los Angeles

Jones Day welcomes prominent life sciences partner in Boston

Maureen Bennett has joined the Boston Office of global law firm Jones Day as a partner in the Health Care and Life Sciences practices.

Previously Co-Chair of Squire Patton Boggs’ Healthcare & Life Sciences Industry Group, Ms. Bennett represents life science and health care entities in a wide range of corporate and commercial transactions, with a particular emphasis on multijurisdictional clinical trials, cross-border transactions, and strategic commercial matters, such as research and development arrangements. More >>

Tags:  Jones Day | Boston

Debevoise Advises Verizon Communications in Sale of Local Wireline Operations Serving California, Florida and Texas for $10.54 Billion

Debevoise & Plimpton LLP is serving as counsel to Verizon Communications Inc. in the sale of its local wireline operations serving customers in California, Florida and Texas to Frontier Communications Corporation. Frontier will pay Verizon approximately $10.54 billion (approximately $9.9 billion in cash, plus $600 million in assumed debt) for the business and related assets in these states. More >>

Tags:  Debevoise & Plimpton LLP

Ropes & Gray Counsels Pfizer in $17 Billion Acquisition of Hospira

Ropes & Gray advised Pfizer Inc. on its definitive agreement to acquire Hospira, the Lake Forest, Ill.-based leading provider of injectable drugs and infusion technologies and a worldwide leader in biosimilars, for a total value of approximately $17 billion. The deal was announced Feb. 5 and is expected to close in the second half of 2015. More >>

Tags:  Ropes & Gray LLP | Boston

Simpson Thacher Represents the Initial Purchasers in Micron Technology’s $1.0 Billion Senior Notes Offering

The Firm recently represented the initial purchasers, led by Goldman, Sachs & Co., Morgan Stanley and Credit Suisse, in connection with Micron Technology, Inc.’s offering of $1.0 billion aggregate principal amount of 5.25% Senior Notes due 2023. The notes were offered in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended. More >>

Tags:  Simpson Thacher & Bartlett LLP | Palo Alto